about
Human von Willebrand factor/factor VIII concentrates in the management of pediatric patients with von Willebrand disease/hemophilia ANonsense-mediated mRNA decay among coagulation factor genesAn overview of three promising mechanical, optical, and biochemical engineering approaches to improve selective photothermolysis of refractory port wine stainsPostpartum Hemorrhage in Women with Von Willebrand Disease - A Retrospective Observational StudyVon Willebrand disease: an overviewContrast ultrasound imaging of the aorta alters vascular morphology and circulating von Willebrand factor in hypercholesterolemic rabbits.Critical von Willebrand factor A1 domain residues influence type VI collagen binding.The role of von Willebrand factor in hemorrhagic and thrombotic disorders.Practical aspects of DDAVP use in patients with von Willebrand Disease undergoing invasive procedures: a European survey.Tranexamic acid for treatment and prophylaxis of bleeding and hyperfibrinolysis.The European standards of Haemophilia CentresZebrafish von Willebrand factor.Pregnancy and delivery in women with von Willebrand's disease and different von Willebrand factor mutations.A von Willebrand factor fragment containing the D'D3 domains is sufficient to stabilize coagulation factor VIII in miceUpdate on the pathophysiology and classification of von Willebrand disease: a report of the Subcommittee on von Willebrand Factor.Quantification of perioperative changes in von Willebrand factor and factor VIII during elective orthopaedic surgery in normal individuals.Recommendations for the transfusion management of patients in the peri-operative period. I. The pre-operative periodCost-consequence analysis of long-term prophylaxis in the treatment of von Willebrand disease in the Italian context.Porcine and canine von Willebrand factor and von Willebrand disease: hemostasis, thrombosis, and atherosclerosis studies.Successful aortic aneurysm repair in a woman with severe von Willebrand (type 3) disease.Treatment of patients with von Willebrand disease.Prothrombin Time and Activated Partial Thromboplastin Time Testing: A Comparative Effectiveness Study in a Million-Patient Sample.Post-tonsillectomy bleeding in children with von Willebrand disease: a single-institution experience.Utility of a high VWF: FVIII ratio in preventing FVIII accumulation: a study in VWF-deficient mice.Correction of a murine model of von Willebrand disease by gene transfer.Blood coagulation and its regulation by anticoagulant pathways: genetic pathogenesis of bleeding and thrombotic diseases.In vivo gene transfer strategies to achieve partial correction of von Willebrand disease.Hemostatic efficacy, safety, and pharmacokinetics of a recombinant von Willebrand factor in severe von Willebrand diseaseThrombotic complications in von Willebrand disease.Von Willebrand's disease: clinical management.The rule of four: a systematic approach to diagnosis of common pediatric hematologic and oncologic disorders.Recommendations for the implementation of a Patient Blood Management programme. Application to elective major orthopaedic surgery in adults.Intravenous DDAVP and factor VIII-von Willebrand factor concentrate for the treatment and prophylaxis of bleedings in patients With von Willebrand disease type 1, 2 and 3.Advances in the diagnosis and management of von Willebrand disease.How do you treat bleeding disorders with desmopressin?Principles of care for the diagnosis and treatment of von Willebrand disease.Management of inherited von Willebrand disease in 2007.Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial.Changes of von Willebrand Factor during Pregnancy in Women with and without von Willebrand Disease.Use of recombinant factor VIIa in inherited and acquired von Willebrand disease.
P2860
Q26738507-1A960E63-22AB-440A-A881-2EBCCF2D2A59Q26747371-93269744-7375-4D16-B0DD-41D02055738BQ26861397-87875AB6-461D-4D43-9B67-B4E370BAAA30Q28552945-CC5A3FA6-3DE9-4339-A4BF-CD5074D0C121Q28742241-0858D339-3E80-40CB-A6FE-779B6158F697Q30461916-7C0E9A1F-DC45-42B4-9E25-B4AFA87FF8ECQ30555005-751D9875-28A6-476E-A5DF-5F72EE64196CQ33374578-E67E87F8-8DD1-4720-A6B2-24530E8B0834Q33424718-E7A7E9C1-6FC8-4CFC-A5B8-662BF4FD9384Q33676496-9207FFCC-B00C-47E7-8C61-B3584D169AB0Q33708927-5BB9D7A9-7AFD-4F6C-9E7F-DF79CBD14C59Q33733889-E6013202-6EE8-40E8-978A-8D568E68ACEAQ33886194-46EA23C0-F413-4234-B49F-2F51866BC2F1Q33917215-A729B387-DE06-4535-8171-6F17BD340084Q33998293-3B1C4840-5A04-4EF6-9EAD-AE7C0549DF94Q34183076-2749881D-D044-4FD1-9579-39BE4EBF7012Q34492729-59858506-F0B7-4C05-B4FE-9CF72C6968D6Q34758065-09645C4D-B522-4946-8071-3145299100DCQ35536246-F114DFD3-3452-4CD7-9CA7-7B0D5C65B797Q35563446-99E7CB24-2D81-4F39-BF91-0536E448478DQ35683876-58DC6D8D-D48C-4127-BC1E-8A8195A8EA0DQ35742281-DA490254-ED9C-4446-A99A-72EA711CA9FAQ35744451-BE73F270-74C1-4337-9586-E713EDDD4037Q35846930-29574B5F-D985-4998-86FB-077FD831B3ABQ35849850-3713F3CB-7B48-4641-92B7-10385BC7EC36Q36044569-3604451C-6246-40A7-9D4E-5CDE7B296D64Q36084450-D0A9BA6D-F65C-4560-98FC-73BDB2C76FA9Q36193201-80D3216A-45E3-4BB9-BA78-81336787E1A8Q36415995-6F4CC7FE-FE3C-4DC4-B781-F499C1BEE64FQ36473103-29A7E133-0A09-4B91-A2D5-3AB4DB0C70E1Q36500415-0C342131-927C-486B-A30E-6DE46D55CEACQ36515685-4376C6DE-F17D-42E5-AB8C-AEAE3EE67C97Q36681790-27834AEE-B2C2-45FA-94B6-2786BD08903FQ36687984-1B966BA0-8C94-41D0-9A27-945C78D59296Q36754092-B4BAAAEF-5F8B-4E67-B06A-C23FCCAB7D8EQ36805813-22E0DC84-9A52-48FD-98C1-C30A3DDCC105Q36911419-6DC12DE0-47C9-4AAD-84F0-4DE8EF4A50FEQ37077021-68A046DC-330C-48A4-89A1-BE980EE67D11Q37078888-DE9D7BEA-C6AF-4D1C-B4DB-BA1373F2EABAQ37080746-1780DE1D-F160-47CE-99C5-5DF1D9F4ABE1
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
name
Treatment of von Willebrand's Disease.
@ast
Treatment of von Willebrand's Disease.
@en
Treatment of von Willebrand's Disease.
@nl
type
label
Treatment of von Willebrand's Disease.
@ast
Treatment of von Willebrand's Disease.
@en
Treatment of von Willebrand's Disease.
@nl
prefLabel
Treatment of von Willebrand's Disease.
@ast
Treatment of von Willebrand's Disease.
@en
Treatment of von Willebrand's Disease.
@nl
P356
P1476
Treatment of von Willebrand's Disease.
@en
P304
P356
10.1056/NEJMRA040403
P407
P577
2004-08-01T00:00:00Z